Literature DB >> 17885268

Viral encephalitis: a clinician's guide.

Tom Solomon1, Ian J Hart, Nicholas J Beeching.   

Abstract

The management of patients with suspected viral encephalitis has been revolutionised in recent years with improved imaging and viral diagnostics, better antiviral and immunomodulatory therapies, and enhanced neurointensive care. Despite this, disasters in patient management are sadly not uncommon. While some patients are attacked with all known antimicrobials with little thought to investigation of the cause of their illness, for others there are prolonged and inappropriate delays before treatment is started. Although viral encephalitis is relatively rare, patients with suspected central nervous system (CNS) infections, who might have viral encephalitis, are not. In addition, the increasing number of immunocompromised patients who may have viral CNS infections, plus the spread of encephalitis caused by arthropod-borne viruses, present new challenges to clinicians. This article discusses the Liverpool approach to the investigation and treatment of adults with suspected viral encephalitis, and introduces the Liverpool algorithm for investigation and treatment of immunocompetent adults with suspected viral encephalitis (available at www.liv.ac.uk/braininfections).

Entities:  

Mesh:

Year:  2007        PMID: 17885268     DOI: 10.1136/jnnp.2007.129098

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  40 in total

Review 1.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

Review 3.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.

Authors:  Melissa L Barker-Haliski; E Jill Dahle; Taylor D Heck; Timothy H Pruess; Fabiola Vanegas; Karen S Wilcox; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2015-03-09       Impact factor: 4.030

5.  Role of 3D Pseudocontinuous Arterial Spin-Labeling Perfusion in the Diagnosis and Follow-Up in Patients with Herpes Simplex Encephalitis.

Authors:  R Li; P-A Shi; T-F Liu; Y Li; Y Wang; K Wu; X-J Chen; H-F Xiao; Y-L Wang; L Ma; X Lou
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

6.  Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats.

Authors:  M A Galic; K Riazi; A K Henderson; S Tsutsui; Q J Pittman
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

Review 7.  Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.

Authors:  Johann Sellner; Eugen Trinka
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

8.  Pitfalls in the management of herpes simplex virus encephalitis.

Authors:  Richard Tolulope Ibitoye; Pamela Sarkar; Satyan Rajbhandari
Journal:  BMJ Case Rep       Date:  2012-10-12

9.  Managing acute central nervous system infections in the UK adult intensive care unit in the wake of UK encephalitis guidelines.

Authors:  D J Stoeter; B D Michael; T Solomon; L Poole
Journal:  J Intensive Care Soc       Date:  2015-05-28

10.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.